Tumor development in BRCA1 knockout mice was reduced by inhibiting RANK/RANKL signaling using Rank:Brca1:p53 triple-knockout mice [73], indicating that activation of the RANK/RANKL signal promotes tumor development. The gene discussed is TP53; the disease is neoplasm.